Other

Gross Unrealized Gains

Alnylam Pharmaceuticals Gross Unrealized Gains decreased by 67.8% to $1.11M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_debt_securities_available_for_sale_accumulated_gro_f6df1b

Historical Data

2 periods
 Q4 '25Q1 '26
Value$3.45M$1.11M
QoQ Change—-67.8%
Range$1.11M – $3.45M

Frequently Asked Questions

What is Alnylam Pharmaceuticals's gross unrealized gains?
Alnylam Pharmaceuticals (ALNY) reported gross unrealized gains of $1.11M in Q1 2026.